Which imaging studies should be ordered for a patient with kidney stones and medullary sponge kidney disease?

Imaging for Kidney Stones with Medullary Sponge Kidney

Order a CT urography (CTU) with IV contrast as the definitive imaging study for patients with kidney stones and medullary sponge kidney disease. This provides both stone detection and the characteristic diagnostic findings of MSK that cannot be adequately visualized with standard noncontrast CT alone 1, 2.

Why CT Urography is Essential for MSK

While noncontrast CT is the gold standard for acute kidney stone evaluation with 97% sensitivity 3, medullary sponge kidney requires visualization of the collecting system architecture that only becomes apparent during the excretory phase with contrast. The pathognomonic findings of MSK—including:

• Precalyceal collecting tubule dilatation (appearing as "bouquet of flowers," "bunch of grapes," or "brush" patterns)
• Medullary nephrocalcinosis
• Medullary cysts
• Papillary duct ectasia

—are only visible when the collecting system is opacified with contrast 1, 4.

The Imaging Algorithm

Initial evaluation:

• If MSK is already confirmed and you're evaluating acute stone symptoms: Start with low-dose noncontrast CT for stone detection 3
• If MSK diagnosis is uncertain or not yet established: Proceed directly to CTU 1, 2

For definitive MSK diagnosis:

• CTU performed with multidetector CT (MDCT) creates images of the renal collecting system with detail equivalent to traditional intravenous pyelography (IVP), which historically was the diagnostic standard 1, 2
• The excretory phase images (delayed phase after contrast administration) are critical for visualizing the dilated collecting ducts characteristic of MSK 1

Important Clinical Considerations

Radiation concerns: Modern dose reduction protocols can achieve radiation exposure below that of conventional IVP while maintaining diagnostic quality 1. This is particularly relevant since MSK patients typically require lifelong imaging surveillance due to recurrent stone disease.

Why standard noncontrast CT fails: Conventional noncontrast CT—while excellent for detecting stones—cannot adequately demonstrate the collecting system abnormalities that define MSK 2. You'll see the stones and nephrocalcinosis, but miss the underlying structural diagnosis.

Follow-up imaging strategy: Once MSK is diagnosed, subsequent acute stone episodes can be evaluated with:

• Low-dose noncontrast CT for stone detection and sizing 3
• Ultrasound for hydronephrosis assessment 5
• KUB radiography for tracking radiopaque stones 5

However, periodic CTU remains valuable for assessing disease progression and new collecting system changes, particularly since MSK patients have recurrent stone disease and may develop complications 1.

Common Pitfalls to Avoid

1. Don't rely solely on noncontrast CT if MSK diagnosis hasn't been established—you'll miss the diagnosis entirely
2. Don't assume ultrasound is adequate—while useful for follow-up hydronephrosis, it cannot visualize the collecting duct abnormalities of MSK
3. Don't order MRI as first-line—limited literature supports its use for MSK diagnosis, and it lacks the spatial resolution of CTU for collecting system detail 3
4. Don't skip the excretory phase—the diagnostic findings only appear on delayed post-contrast images when the collecting system is opacified 1, 2

Bottom line: CTU is both diagnostic for MSK and therapeutic in guiding stone management, making it the single most valuable imaging study for this population 1, 2.